Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01113827 · ClinicalTrials.gov registry record · NA

Effects of Water-soluble Olive Extract Supplementation

A NA study of Healthy, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT01113827 is a NA study of Healthy that has completed, run by University of Texas at Austin. The registered enrollment target is 61 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01113827, a NA study of Healthy, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

Six weeks of supplementation of an olive extract will: * Improve antioxidant status * Reduce inflammation * Reduce muscle damage * Improve exercise performance * Improve exercise recovery as compared to a placebo.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Olive Extract

Study Locations (1)

Texas

  • The University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2010-02
Est. Completion 2012-02
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT01113827

The ClinicalTrials.gov registry entry for NCT01113827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01113827 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01113827 about?

NCT01113827 is a clinical study titled "Effects of Water-soluble Olive Extract Supplementation". Six weeks of supplementation of an olive extract will: * Improve antioxidant status * Reduce inflammation * Reduce muscle damage * Improve exercise performance * Improve exercise recovery as compared to a placebo.

What is the current status of trial NCT01113827?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2010-02. Estimated completion is 2012-02.

What conditions does trial NCT01113827 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01113827?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Olive Extract (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01113827?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01113827 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.